PHAR: A Leading Pharma Stock Ready to Catch Up Egyptian International Pharmaceutical Industries Co.EGX_DLY:PHARmnmabroukw36ix📊 PHAR: A Leading Pharma Stock Ready to Catch Up 🚀 🏛️ The Fundamentals PHAR remains one of the strongest pharmaceutical companies on the EGX, supported by a solid long-term growth story. 💊 The recent announcement regarding EIPICO 3 manufacturing facility provides a meaningful catalyst that could support the next phase of growth. 🏭 🧠 The Pulse While most pharmaceutical stocks rallied strongly last month, PHAR lagged behind the sector. 📊 The recent positive news appears to have provided the catalyst needed for PHAR to begin its own bullish wave. 🚀 The long-term trend remains firmly bullish, and I would not consider exiting the position during normal corrections. 📈 Instead, significant pullbacks can be viewed as opportunities to increase exposure. 💰 🧱 The Key Structural Boundaries Suggested Entries: 96.40, 92.30, and 90.00. 📊 First Target: Triangle breakout target around 105.00. 🎯 Second Target: Rumble annual target around 118.00. 📈 Final Target: Investing.com's fair value estimate around 120.00. 🌟 ⚖️ The Verdict PHAR remains one of the strongest long-term pharmaceutical investments on the EGX. 💊 The recent catalyst may mark the beginning of a catch-up rally after underperforming its peers. 🚀 I prefer accumulating on meaningful pullbacks rather than trying to trade in and out of this long-term uptrend. 📈 If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑